Cue Health Price to Book Ratio 2020-2023 | HLTH

Historical price to book ratio values for Cue Health (HLTH) over the last 10 years. The current price to book ratio for Cue Health as of April 30, 2024 is 0.08.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Cue Health Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2024-04-30 0.14 0.08
2023-12-31 0.16 $1.61 0.10
2023-09-30 0.44 $2.52 0.18
2023-06-30 0.37 $2.77 0.13
2023-03-31 1.82 $3.27 0.56
2022-12-31 2.07 $3.83 0.54
2022-09-30 3.01 $3.95 0.76
2022-06-30 3.20 $4.33 0.74
2022-03-31 6.45 $4.93 1.31
2021-12-31 13.41 $4.83 2.78
2021-09-30 11.81 $4.47 2.64
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.022B $0.071B
Cue Health Inc. is a health technology company. It offers individuals, enterprises, government agencies and healthcare provides access to lab-quality diagnostic testing at home, at work or at the point-of-care, all in a device. Cue Health Inc. is headquartered in San Diego.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $34.790B 19.11
Inspire Medical Systems (INSP) United States $7.322B 0.00
10x Genomics (TXG) United States $3.489B 0.00
IRhythm Technologies (IRTC) United States $3.410B 0.00
Axonics (AXNX) United States $3.396B 0.00
Enovis (ENOV) United States $3.029B 23.01
Azenta (AZTA) United States $2.925B 238.46
Olink Holding AB (publ) (OLK) Sweden $2.864B 0.00
Hims & Hers Health (HIMS) United States $2.685B 0.00
Privia Health (PRVA) United States $2.183B 96.84
Schrodinger (SDGR) United States $1.763B 0.00
Omnicell (OMCL) United States $1.231B 30.12
Phreesia (PHR) United States $1.169B 0.00
Definitive Healthcare (DH) United States $0.817B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.783B 0.00
Standard BioTools (LAB) United States $0.719B 0.00
Fulgent Genetics (FLGT) United States $0.608B 0.00
Talkspace (TALK) United States $0.519B 0.00
Health Catalyst (HCAT) United States $0.367B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.333B 0.00
Clover Health Investments (CLOV) United States $0.312B 0.00
Pulmonx (LUNG) United States $0.293B 0.00
P3 Health Partners (PIII) United States $0.170B 0.00
Butterfly Network (BFLY) United States $0.162B 0.00
American Well (AMWL) United States $0.148B 0.00
MSP Recovery (LIFW) United States $0.139B 0.00
Augmedix (AUGX) United States $0.133B 0.00
Outset Medical (OM) United States $0.131B 0.00
TruBridge (TBRG) United States $0.116B 4.94
111 (YI) China $0.087B 0.00
Future Health ESG (FHLT) United States $0.073B 0.00
SHL Telemedicine (SHLT) Israel $0.071B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
EUDA Health Holdings (EUDA) Singapore $0.047B 0.00
Movano (MOVE) United States $0.044B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.034B 0.00
Akili (AKLI) United States $0.031B 0.00
Bullfrog AI Holdings (BFRG) United States $0.025B 0.00
CareCloud (CCLD) United States $0.018B 0.00
Streamline Health Solutions (STRM) United States $0.018B 0.00
ETAO (ETAO) United States $0.016B 0.00
Strata Skin Sciences (SSKN) United States $0.014B 0.00
Biotricity (BTCY) United States $0.013B 0.00
Transgenomic (PRPO) United States $0.008B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Syra Health (SYRA) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00